communicable disease

Kitsap Respiratory Illness Report: Week 12 (3/16/2025-3/22/2025)

| March 28, 2025

In week ending March 22, local indicators for influenza continued to decrease but remained high, while local indicators for RSV remained elevated, and indicators for COVID-19 remained low. Other Puget Sound counties observed similar trends. Regional laboratory surveillance most frequently detected influenza A and rhinovirus among clinical respiratory specimens. 1.3% of emergency department (ED) visits were attributable to influenza, and … Kitsap Respiratory Illness Report: Week 12 (3/16/2025-3/22/2025)

Kitsap Respiratory Illness Report: Week 11 (3/9/2025 – 3/15/2025)

| March 20, 2025

In week ending March 15, local indicators for influenza and respiratory syncytial virus (RSV) continued to decrease but remained high, while local indicators for COVID-19 remained low. Hospitalizations for COVID-19 and influenza have also returned to non-peak levels. Regional laboratory surveillance most frequently detected influenza A among clinical respiratory specimens. 1.6% of emergency department (ED) visits were attributable to … Kitsap Respiratory Illness Report: Week 11 (3/9/2025 – 3/15/2025)

Kitsap Respiratory Illness Report: Week 10 (3/2/2025 – 3/8/2025)

| March 13, 2025

In week ending March 8, local indicators for influenza and respiratory syncytial virus (RSV) remained high but continued to decrease, while local indicators for COVID-19 remained low. Hospitalizations for COVID-19 and influenza also decreased. Regional laboratory surveillance most frequently detected influenza A among clinical respiratory specimens. 2.4% of emergency department (ED) visits were attributable to influenza, and fewer than 10 … Kitsap Respiratory Illness Report: Week 10 (3/2/2025 – 3/8/2025)

Kitsap Respiratory Illness Report: Week 52 (12/22/2024-12/28/2024)

| January 2, 2025

In week ending December 28, local indicators for influenza were high and continuing to increase for a second week, surpassing peak flu activity observed last year. Local indicators for respiratory syncytial virus (RSV) were also high and rising. Local indicators for COVID-19 remained minimal. Regional laboratory surveillance most frequently detected RSV and Influenza A among clinical respiratory specimens. Elevated pertussis activity continues … Kitsap Respiratory Illness Report: Week 52 (12/22/2024-12/28/2024)

Kitsap Respiratory Illness Report: 10/27/24-11/2/24

| November 7, 2024

View this report as an interactive dashboard. In week ending November 2, local indicators for COVID-19 and respiratory syncytial virus (RSV) remained minimal. Influenza indicators remained low but showed signs that local flu activity is beginning to rise. Regional laboratory data are most frequently detecting rhinovirus among clinical respiratory specimens. 0.7% of emergency department (ED) visits were … Kitsap Respiratory Illness Report: 10/27/24-11/2/24

Health Advisory: 2024-2025 COVID-19 vaccines approved

| September 11, 2024

ACTIONS REQUESTED  BE AWARE that updated (2024–2025) COVID-19 vaccines have been approved and authorized by the FDA. The new formulations provide better protection against currently circulating COVID-19 variants. For more information, see: DISCONTINUE USE of the 2023–2024 Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines. These formulations are no longer authorized by the FDA. BE AWARE that there are two types … Health Advisory: 2024-2025 COVID-19 vaccines approved

TB on the Radar: A tuberculosis presentation for Kitsap healthcare providers

| June 17, 2024

On June 13, 2024, Kitsap Public Health District presented “TB on the Radar,” a special public health presentation highlighting the ongoing risk from tuberculosis (TB), public health response to TB, and healthcare best practices for testing, diagnosis, and treatment of TB. The presentation featured insights from local and state TB experts and a Q&A with panelists.  … TB on the Radar: A tuberculosis presentation for Kitsap healthcare providers